Open Access

Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma

  • Authors:
    • Haoxun Wang
    • Jing Wang
    • Bingbo Zhao
  • View Affiliations

  • Published online on: March 26, 2019     https://doi.org/10.3892/ol.2019.10189
  • Pages: 4859-4864
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma was investigated. Thirty-six patients with cardiac carcinoma treated in The Second Affiliated Hospital of Zhengzhou University were selected. After the radical operation of cardiac carcinoma, carcinoma tissues were taken, and the corresponding para-carcinoma tissues were used as controls. p16 and cyclin D1 messenger ribonucleic acid (mRNA) and protein expression in cardiac carcinoma tissues and para-carcinoma tissues were detected via quantitative polymerase chain reaction (qPCR) and western blot analysis. The survival time and pathological conditions of patients with cardiac carcinoma were recorded in detail, and correlation of p16 and cyclin D1 with incidence and prognosis of cardiac carcinoma was studied. In cardiac carcinoma tissues, the p16 mRNA and protein expression levels were significantly lower than those in para-carcinoma tissues (P<0.01), but the cyclin D1 mRNA and protein expression levels were significantly higher than those in para-carcinoma tissues (P<0.01). The expression of p16 and cyclin D1 protein had correlation with the tumor size, lymph node metastasis and tumor-node-metastasis stage of cardiac carcinoma (P<0.01). There was a negative correlation between expression of p16 and cyclin D1 in cardiac carcinoma (P<0.01). According to Kaplan-Meier survival analysis, the survival rate of patients with high expression of p16 was obviously higher than that of patients with low expression of p16 (P<0.01), while the survival rate of patients with high expression of cyclin D1 was obviously lower than that of patients with low expression of cyclin D1 (P<0.01). Both p16 and cyclin D1 are closely related to the incidence and prognosis of cardiac carcinoma, which may become indexes for the incidence and prognosis of cardiac carcinoma.

References

1 

Wang HF and Lv JQ: The clinical evaluation of tegafur gimeracil oteracil combined with THP and DDP for second-line treatment of advanced cardiac carcinoma. Cell Biochem Biophys. 72:695–699. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Chen G, Xu M, Chen J, Hong L, Lin W, Zhao S, Zhang G, Dan G and Liu S: Clinicopathological features and increased expression of toll-like receptor 4 of gastric cardia cancer in a high-risk Chinese population. J Immunol Res. 2018:71328682018. View Article : Google Scholar : PubMed/NCBI

3 

Lagergren F, Xie SH, Mattsson F and Lagergren J: Updated incidence trends in cardia and non-cardia gastric adenocarcinoma in Sweden. Acta Oncol. 9:1–6. 2018.

4 

Padrão AI, Nogueira-Ferreira R, Vitorino R, Carvalho D, Correia C, Neuparth MJ, Pires MJ, Faustino-Rocha AI, Santos LL, Oliveira PA, et al: Exercise training protects against cancer-induced cardiac remodeling in an animal model of urothelial carcinoma. Arch Biochem Biophys. 645:12–18. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Xie CM, Lin XT, Wu D, Tan Y, Cheng CHK and Zhang J: Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway. Oncotarget. 9:13783–13795. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Xi S, Payabyab EC, Straughan DM, Reardon ES, Zhang M, Hong JA, Ripley RT, Hoang CD and Schrump DS: Asbestos induces epigenetic repression of ras association domain-containing protein 1, p16 kinase 4a inhibitor, and p14 alternative reading frame in normal human mesothelial cells. Ann Am Thorac Soc. 15 (Suppl 2):S1232018. View Article : Google Scholar : PubMed/NCBI

7 

Liu JQ, Zhang QH and Wang ZL: Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma. World J Otorhinolaryngol Head Neck Surg. 1:50–56. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Dreyer JH, Hauck F, Barros MHM and Niedobitek G: pRb and cyclinD1 complement p16 as immunohistochemical surrogate markers of HPV infection in head and neck cancer. Appl Immunohistochem Mol Morphol. 25:366–373. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang J and Zhao F: The risk factor of gallbladder cancer: Hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. Exp Mol Pathol. 91:569–577. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Pu X, Zhu L, Fu Y, Fan Z, Zheng J, Zhang B, Yang J, Guan W, Wu H, Ye Q, et al: Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer. Medicine (Baltimore). 97:e03532018. View Article : Google Scholar : PubMed/NCBI

11 

Livak KJ and Scmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Chow CM, Thavendiranathan D, Haq R, Barfett JJ, Petrella TM, et al: Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol. 261:228–233. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Boisclair Lachance JF, Webber JL, Hong L, Dinner AR and Rebay I: Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev. 32:389–401. 2018. View Article : Google Scholar : PubMed/NCBI

14 

Chen Y, Kang Y, Hong L and Yao H: Hypoglycemia caused by co-secretion of insulin from lung tumor and cardia cancer: First case report. Sao Paulo Med J. Nov 17–2017.(Epub ahead of print). View Article : Google Scholar

15 

Zhao X, Song T, He Z, Tang L and Zhu Y: A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma. Med Oncol. 27:985–991. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Prigenzi KCK, Heinke T, Salim RC and Focchi GRA: Dual p16 and Ki-67 expression in liquid-based cervical cytological samples compared to Pap cytology findings, biopsies, and HPV testing in cervical cancer screening: A diagnostic accuracy study. Acta Cytol. 62:104–114. 2018. View Article : Google Scholar : PubMed/NCBI

17 

Zhou N and Gu Q: Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis. Genes Nutr. 5:63–75. 2015.

18 

Tang Y, Berlind J and Mavila N: Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells. Cell Commun Signal. 16:92018. View Article : Google Scholar : PubMed/NCBI

19 

Cao L, Liu Y, Wang D, Huang L, Li F, Liu J, Zhang C, Shen Z, Gao Q, Yuan W, et al: MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling. J Exp Clin Cancer Res. 37:832018. View Article : Google Scholar : PubMed/NCBI

20 

Fu ZJ, Ma ZY, Wang QR, Lei DP, Wang R, Liu CX and Pan XL: Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients. Clin Exp Metastasis. 25:887–892. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Liu T, Niu Y, Feng Y, Niu R, Yu Y, Lv A and Yang Y: Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Hum Pathol. 39:1637–1646. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, H., Wang, J., & Zhao, B. (2019). Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma. Oncology Letters, 17, 4859-4864. https://doi.org/10.3892/ol.2019.10189
MLA
Wang, H., Wang, J., Zhao, B."Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma". Oncology Letters 17.6 (2019): 4859-4864.
Chicago
Wang, H., Wang, J., Zhao, B."Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma". Oncology Letters 17, no. 6 (2019): 4859-4864. https://doi.org/10.3892/ol.2019.10189